Cargando…

The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study

OBJECTIVE: Cystic fibrosis associated liver disease (CFLD) is the third largest cause of mortality in CF. Our aim was to define the burden of CFLD in the UK using national registry data and identify risk factors for progressive disease. METHODS: A longitudinal population-based cohort study was condu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toledano, M. B., Mukherjee, S. K., Howell, J., Westaby, D., Khan, S. A., Bilton, D., Simmonds, N. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448894/ https://www.ncbi.nlm.nih.gov/pubmed/30947265 http://dx.doi.org/10.1371/journal.pone.0212779

Ejemplares similares

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK
por: Keogh, Ruth H., et al.
Publicado: (2020)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
por: George, P M, et al.
Publicado: (2011)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series
por: Kayria, Muttardi, et al.
Publicado: (2017)

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review
por: Stanford, Gemma E., et al.
Publicado: (2022)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden
por: Cameron, Rory A., et al.
Publicado: (2022)

Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis
por: Stanford, Gemma, et al.
Publicado: (2019)

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
por: Bessonova, Leona, et al.
Publicado: (2018)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study
por: Khan, Muhammad Saleem, et al.
Publicado: (2022)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis
por: Altabee, Rana, et al.
Publicado: (2022)

Diabetes as a Determinant of Mortality in Cystic Fibrosis
por: Chamnan, Parinya, et al.
Publicado: (2010)

Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial
por: Stanford, Gemma, et al.
Publicado: (2020)

Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data()
por: Keogh, Ruth H., et al.
Publicado: (2018)

The burden of cystic fibrosis in the Medicaid population
por: Hassan, Mariam, et al.
Publicado: (2018)

Liver disease in cystic fibrosis
por: Kobelska-Dubiel, Natalia, et al.
Publicado: (2014)

Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015)

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
por: Elborn, JS, et al.
Publicado: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Cystic fibrosis associated liver disease in children
por: Valamparampil, Joseph J, et al.
Publicado: (2021)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Liver Disease in Cystic Fibrosis: an Update
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2013)

Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
por: Bar-Yoseph, Ronen, et al.
Publicado: (2019)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019)

Cystic Fibrosis Liver Disease: Know More
por: Al Sinani, Siham, et al.
Publicado: (2019)

Health State Utility Data in Cystic Fibrosis: A Systematic Review
por: Mohindru, Bishal, et al.
Publicado: (2019)

Erratum to: Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
Publicado: (2021)

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools()
por: Scott, Jennifer A., et al.
Publicado: (2023)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study
por: de Jong, C C M, et al.
Publicado: (2020)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Caregiver burden in cystic fibrosis: a systematic literature review
por: Daly, Conor, et al.
Publicado: (2022)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

A82 PREVALENCE AND NON-INVASIVE SCREENING FOR CYSTIC FIBROSIS RELATED LIVER DISEASE IN A COHORT FOLLOWED AT A CYSTIC FIBROSIS REFERENCE CENTER
por: Coman, D E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tups0guftkdj64nlq7kj9ovioa